2-amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (β-site APP cleaving enzyme):: Use of structure based design to convert a micromolar hit into a nanomolar lead

被引:127
作者
Baxter, Ellen W. [1 ]
Conway, Kelly A. [1 ]
Kennis, Ludo [1 ]
Bischoff, Francois [1 ]
Mercken, Marc H. [1 ]
De Winter, Hans L. [1 ]
Reynolds, Charles H. [1 ]
Tounge, Brett A. [1 ]
Luo, Chi [1 ]
Scott, Malcolm K. [1 ]
Huang, Yifang [1 ]
Braeken, Mirielle [1 ]
Pieters, Sere M. A. [1 ]
Berthelot, Didier J. C. [1 ]
Masure, Stefan [1 ]
Bruinzeel, Wouter D. [1 ]
Jordan, Alfonzo D. [1 ]
Parker, Michael H. [1 ]
Boyd, Robert E. [1 ]
Qu, Junya [1 ]
Alexander, Richard S. [1 ]
Brenneman, Douglas E. [1 ]
Reitz, Allen B. [1 ]
机构
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, Spring House, PA 19477 USA
关键词
X-RAY CRYSTALLOGRAPHY; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; SECRETASE BACE-1; IN-VIVO; EXPRESSION; DISCOVERY; LIGANDS; POTENT; BRAIN;
D O I
10.1021/jm0705408
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new aspartic protease inhibitory chemotype bearing a 2-amino-3,4-dihydroquinazoline ring was identified by high-throughput screening for the inhibition of BACE-1. X-ray crystallography revealed that the exocyclic amino group participated in a hydrogen bonding array with the two catalytic aspartic acids of BACE-1 (Asp(32), Asp(228)). BACE-1 inhibitory potency was increased (0.9 mu M to 11 nM K-i) by substitution into the unoccupied S-1 ' pocket.
引用
收藏
页码:4261 / 4264
页数:4
相关论文
共 30 条
[1]   The novel β-secretase inhibitor KMI-429 reduces amyloid β peptide production in amyloid precursor protein transgenic and wild-type mice [J].
Asai, M ;
Hattori, C ;
Iwata, N ;
Saido, TC ;
Sasagawa, N ;
Szabó, B ;
Hashimoto, Y ;
Maruyama, K ;
Tanuma, S ;
Kiso, Y ;
Ishiura, S .
JOURNAL OF NEUROCHEMISTRY, 2006, 96 (02) :533-540
[2]   Recombinant insect cell expression and purification of human β-secretase (BACE-1) for X-ray crystallography [J].
Bruinzeel, W ;
Yon, J ;
Giovannelli, S ;
Masure, S .
PROTEIN EXPRESSION AND PURIFICATION, 2002, 26 (01) :139-148
[3]   The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease [J].
Catalano, Susan M. ;
Dodson, Elizabeth C. ;
Henze, Darrell A. ;
Joyce, Joseph G. ;
Krafft, Grant A. ;
Kinney, Gene G. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (06) :597-608
[4]   In vivo inhibition of Aβ production by memapsin 2 (β-secretase) inhibitors [J].
Chang, WP ;
Koelsch, G ;
Wong, S ;
Downs, D ;
Da, HN ;
Weerasena, V ;
Gordon, B ;
Devasamudram, T ;
Bilcer, G ;
Ghosh, AK ;
Tang, J .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (06) :1409-1416
[5]   Tau therapeutic strategies for the treatment of Alzheimer's disease [J].
Churcher, Ian .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (06) :579-595
[6]   Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of β-secretase [J].
Congreve, Miles ;
Aharony, David ;
Albert, Jeffrey ;
Callaghan, Owen ;
Campbell, James ;
Carr, Robin A. E. ;
Chessari, Gianni ;
Cowan, Suzanna ;
Edwards, Philip D. ;
Frederickson, Martyn ;
McMenamin, Rachel ;
Murray, Christopher W. ;
Patel, Sahil ;
Wallis, Nicola .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) :1124-1132
[7]  
DEPEREZ RMB, 1986, J ORG CHEM, V51, P2039
[8]  
Freyne E.J.E., 1990, European Patent, Patent No. 371564
[9]   Design of potent inhibitors for human brain memapsin 2 (β-secretase) [J].
Ghosh, AK ;
Shin, DW ;
Downs, D ;
Koelsch, G ;
Lin, XL ;
Ermolieff, J ;
Tang, J .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (14) :3522-3523
[10]   A century of Alzheimer's disease [J].
Goedert, Michel ;
Spillantini, Maria Grazia .
SCIENCE, 2006, 314 (5800) :777-781